Document is current
Any future updates will be listed below
-
Authors
Melgosa Ramos, Francisco Javier https://orcid.org/0000-0003-2121-6727
Guillén Climent, Santiago
Galarreta Pascual, Marta
Martorell, Antonio
Matellanes Palacios, María
Roca Ginés, Juncal
Sabater Abad, Javier
Bernia Petit, Eduardo
González Delgado, Víctor
- License Information
-
More Information
Article History
Received: 28 December 2025
Accepted: 3 February 2026
First Online: 24 February 2026
Declarations
:
: Francisco Javier Melgosa Ramos has received honoraria and/or travel grants and/or has acted as an advisory board member for Novartis, AbbVie, Janssen Cilag, UCB, Lilly, LEO Pharma, L’Oréal, Sanofi, Almirall, and Amgen. Antonio Martorell has acted as a consultant, advisory board member, and investigator, and has received honoraria from Novartis, AbbVie, Janssen Cilag, UCB, Lilly, LEO Pharma, L’Oréal, Sanofi, Sandoz, Boehringer Ingelheim, and Amgen. Santiago Guillén Climent, Marta Galarreta Pascual, María Matellanes Palacios, Juncal Roca Ginés, Javier Sabater Abad, Eduardo Bernia Petit, and Víctor González Delgado have nothing to disclose.
: The study was conducted in compliance with national regulations and ethical principles governing biomedical research in Spain. According to the national legislation (Law 14/2007 on Biomedical Research and the EU General Data Protection Regulation [GDPR] 2016/679), research involving anonymized data may be exempt from requiring institutional review board (IRB) approval. In this case, owing to the full anonymization of the data, an exemption was granted in accordance with the applicable regulations. The study ensured compliance with all relevant ethical and data protection guidelines.
